
Sign up to save your podcasts
Or


Dr. Tassa Saldi is an accomplished molecular biologist with more than 25 years of research experience in RNA biology, infectious disease, and molecular pathogen detection. Dr. Saldi graduated Summa Cum Laude with a degree in Molecular Biology. She completed her graduate and postdoctoral studies at the University of Colorado, where she studied RNA structure, small RNAs and RNA processing. She was awarded a prestigious fellowship from the American Cancer Society and was one of eighteen doctoral fellows nationwide invited to present her research at the Aspen Cancer Conference. Dr. Saldi has authored more than 20 peer-reviewed articles in top-tier journals. As the Chief Science Officer and co-founder of TUMI Genomics, Dr. Saldi continues to use her expertise to provide the cannabis industry with reliable, accurate diagnostic tools and pathogen mitigation guidance.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
By Tad Hussey4.8
703703 ratings
Dr. Tassa Saldi is an accomplished molecular biologist with more than 25 years of research experience in RNA biology, infectious disease, and molecular pathogen detection. Dr. Saldi graduated Summa Cum Laude with a degree in Molecular Biology. She completed her graduate and postdoctoral studies at the University of Colorado, where she studied RNA structure, small RNAs and RNA processing. She was awarded a prestigious fellowship from the American Cancer Society and was one of eighteen doctoral fellows nationwide invited to present her research at the Aspen Cancer Conference. Dr. Saldi has authored more than 20 peer-reviewed articles in top-tier journals. As the Chief Science Officer and co-founder of TUMI Genomics, Dr. Saldi continues to use her expertise to provide the cannabis industry with reliable, accurate diagnostic tools and pathogen mitigation guidance.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

572 Listeners

593 Listeners

511 Listeners

254 Listeners

115 Listeners

446 Listeners

12 Listeners

100 Listeners

52 Listeners

133 Listeners

341 Listeners

220 Listeners

129 Listeners

29 Listeners

47 Listeners